Literature DB >> 35146223

Large symptomatic carotid web in young African-Swedish man.

Peter Gillgren1, Claes Skiöldebrand1.   

Abstract

Entities:  

Keywords:  Carotid arteries; Carotid web; Cryptogenic stroke; Intimal fibromuscular dysplasia; Risk factors

Year:  2021        PMID: 35146223      PMCID: PMC8818910          DOI: 10.1016/j.jvscit.2021.11.009

Source DB:  PubMed          Journal:  J Vasc Surg Cases Innov Tech        ISSN: 2468-4287


× No keyword cloud information.
Debate is ongoing regarding whether carotid web (CW)—a type of fibromuscular dysplasia of the intima—can cause brain embolization and, thereby, ischemic stroke. Sole medical treatment of the condition has been associated with high recurrence rates. Studies have shown a strong association with cryptogenic or occult ipsilateral ischemic stroke through embolization, with a high number of patients of African descendant included in reported case series.1, 2, 3 A 32-year-old nonsmoking Cameroon-born previously healty African-Swedish man, with no risk factors, had presented with a National Institutes of Health stroke scale score 11 stroke, with left-sided hemiplegia, aphasia, and central facial nerve palsy. Computed tomography (CT) angiography showed occlusions in M2, M3, and M4 and a 4 × 5-cm frontotemporal infarction of the right hemisphere. Duplex ultrasound and CT angiography revealed a carotid web in the right internal carotid artery (A/Cover). The left carotid was normal. The ensuing attempted intra-arterial thrombolysis showed that occluded right-sided M3 and M4 branches remained. Therefore, mechanical thrombectomy was performed with restoration of blood flow. The findings from transesophageal echocardiography, telemetry, and lipid and biomarkers of systemic inflammation measurements were all normal. After the stroke, the patient was discharged with dual antiplatelet treatment (aspirin and clopidogrel) for 3 weeks, followed by a single aspirin and atorvastatin at 40 mg. The patient provided written informed consent for the report of his case details and imaging studies (August 19, 2021). Because the CW was considered the source of emboli and rehabilitation was successful (National Institutes of Health stroke scale score of 0 at 3 months), the patient was scheduled for delayed surgery and underwent carotid “webectomy.” The membranous structure removed was more prominent and voluminous than expected (B and C). Using a surgical dissector, the CW loosened easily (D). Because the artery was wide and the patient young, primary suture of the artery was performed. The patient was discharged with a prescription for aspirin for 4 months, and atorvastatin was discontinued after 1 month. His recovery was uneventful. Histologic examination showed fibromuscular dysplasia. The patient has been scheduled for a renal artery magnetic resonance imaging study. The CW depicted in the CT in the present patient of African descent was considered the source of the ischemic stroke. CW can lead to embolic ischemic stroke. Thus, in countries with a low number of persons of African descent, CW could be underrecognized. After meticulous examination, these patients could be considered for carotid revascularization.
  3 in total

Review 1.  Carotid webs associated with ischemic stroke. Updated general review and research directions.

Authors:  S Olindo; G Marnat; N Chausson; C Turpinat; D Smadja; N Gaillard
Journal:  Rev Neurol (Paris)       Date:  2021-01-15       Impact factor: 2.607

2.  Carotid web prevalence in a large hospital-based cohort and its association with ischemic stroke.

Authors:  Janet Mei; Duan Chen; Charles Esenwa; Menachem Gold; Judah Burns; Richard Zampolin; Shira E Slasky
Journal:  Clin Anat       Date:  2021-05-07       Impact factor: 2.414

3.  Internal Carotid Artery Web as the Cause of Recurrent Cryptogenic Ischemic Stroke.

Authors:  Jon Antigüedad-Muñoz; Patricia de la Riva; Gorka Arenaza Choperena; Amaia Muñoz Lopetegi; Naiara Andrés Marín; Gorka Fernández-Eulate; Manuel Moreno Valladares; Maite Martínez Zabaleta
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-01-10       Impact factor: 2.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.